The Opioid Files Inside the opioid industry’s marketing machine Unsealed court documents reveal how drug companies ramped up sales during the epidemic. In the Oklahoma case, Judge Balkman said in his ruling that Johnson & Johnson sales reps visited medical professionals in Oklahoma “hundreds of thousands of times” on opioid sales calls over two decades. A 2002 presentation for Johnson & Johnson sales reps highlights promotional materials they could use in selling Duragesic, a fentanyl-based patch for severe pain. An attorney for Johnson & Johnson and Janssen said company employees complied with the law. In his ruling against Johnson & Johnson and Janssen in Oklahoma, Balkman singled out the pain groups.

Source: Washington Post December 06, 2019 15:11 UTC